IBDEI2KZ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41190,1,3,0)
 ;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,41190,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,41190,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,41191,0)
 ;;=E10.44^^152^2029^1
 ;;^UTILITY(U,$J,358.3,41191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41191,1,3,0)
 ;;=3^DM Type 1 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,41191,1,4,0)
 ;;=4^E10.44
 ;;^UTILITY(U,$J,358.3,41191,2)
 ;;=^5002608
 ;;^UTILITY(U,$J,358.3,41192,0)
 ;;=E10.49^^152^2029^25
 ;;^UTILITY(U,$J,358.3,41192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41192,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,41192,1,4,0)
 ;;=4^E10.49
 ;;^UTILITY(U,$J,358.3,41192,2)
 ;;=^5002609
 ;;^UTILITY(U,$J,358.3,41193,0)
 ;;=E10.59^^152^2029^22
 ;;^UTILITY(U,$J,358.3,41193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41193,1,3,0)
 ;;=3^DM Type 1 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,41193,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,41193,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,41194,0)
 ;;=E10.610^^152^2029^9
 ;;^UTILITY(U,$J,358.3,41194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41194,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,41194,1,4,0)
 ;;=4^E10.610
 ;;^UTILITY(U,$J,358.3,41194,2)
 ;;=^5002613
 ;;^UTILITY(U,$J,358.3,41195,0)
 ;;=E10.618^^152^2029^23
 ;;^UTILITY(U,$J,358.3,41195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41195,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,41195,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,41195,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,41196,0)
 ;;=E10.630^^152^2029^30
 ;;^UTILITY(U,$J,358.3,41196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41196,1,3,0)
 ;;=3^DM Type 1 w/ Peridontal Disease
 ;;^UTILITY(U,$J,358.3,41196,1,4,0)
 ;;=4^E10.630
 ;;^UTILITY(U,$J,358.3,41196,2)
 ;;=^5002619
 ;;^UTILITY(U,$J,358.3,41197,0)
 ;;=E10.638^^152^2029^27
 ;;^UTILITY(U,$J,358.3,41197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41197,1,3,0)
 ;;=3^DM Type 1 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,41197,1,4,0)
 ;;=4^E10.638
 ;;^UTILITY(U,$J,358.3,41197,2)
 ;;=^5002620
 ;;^UTILITY(U,$J,358.3,41198,0)
 ;;=E10.641^^152^2029^15
 ;;^UTILITY(U,$J,358.3,41198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41198,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,41198,1,4,0)
 ;;=4^E10.641
 ;;^UTILITY(U,$J,358.3,41198,2)
 ;;=^5002621
 ;;^UTILITY(U,$J,358.3,41199,0)
 ;;=E10.649^^152^2029^16
 ;;^UTILITY(U,$J,358.3,41199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41199,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,41199,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,41199,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,41200,0)
 ;;=E10.65^^152^2029^14
 ;;^UTILITY(U,$J,358.3,41200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41200,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,41200,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,41200,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,41201,0)
 ;;=E10.69^^152^2029^29
 ;;^UTILITY(U,$J,358.3,41201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41201,1,3,0)
 ;;=3^DM Type 1 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,41201,1,4,0)
 ;;=4^E10.69
 ;;^UTILITY(U,$J,358.3,41201,2)
 ;;=^5002624
 ;;^UTILITY(U,$J,358.3,41202,0)
 ;;=E10.8^^152^2029^33
 ;;^UTILITY(U,$J,358.3,41202,1,0)
 ;;=^358.31IA^4^2
